BPA Call W91YTZ23A0014-W91YTZ24F0159
Award Date 6/12/24
Potential Completion Date 7/31/24
Potential Value $19K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $21,685.45 firm fixed price Blank Purchase Agreement (BPA) call to Cerilliant Corporation for drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine, and/or tissue testing. This contract, which was not issued under any set-aside designation, leverages Cerilliant's established Indefinite Delivery Vehicle with the Defense Health Agency—a $250,000 BPA for drug reference standards and laboratory supplies...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- This federal contract award was issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The $17,226.00 Blanket Purchase Agreement (BPA) Call contract is for the supply of FTDTL CERILLIANT SUPPLIES-MEADE, which are drug reference standards used for screening and confirmation testing of service member specimens. Cerilliant, a foreign-owned, for-profit manufacturer, has a strong track record of providing analytical standards and...
- Cerilliant Corporation, doing business as Cerilliant API Services LLC, was awarded a Blanket Purchase Agreement (BPA) call valued at $15,522.70 by the Defense Health Agency on August 1, 2024, with an ultimate completion date of August 15, 2024. This Firm Fixed Price contract, designated FTDTL BPA CALL W91YTZ23A0014, will be performed at Fort Meade, Maryland, and involves the supply of certified reference materials and laboratory supplies. The award carries no set-aside designation, reflecting...
- This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
- Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...
- Cerilliant Corporation was awarded a $4,912.10 firm fixed price call against the Defense Health Agency's (DHA) CERILLIANT BPA T/O PAIN MANAGEMENT MULTI-COMPONENT blanket purchase agreement (BPA). The contract calls for Cerilliant to provide multi-component pain management products and services in support of DHA programs, with work taking place in Fort Meade, Maryland. No set-aside designation was applied to this award. All work under the contract is scheduled for completion by January 3, 2023.
- This federal contract award, valued at $1,253.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Morphine Sulfate 4 mg/mL vials, a critical medical commodity, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $1,034.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Morphine Sulfate 4 mg/mL vials to support military healthcare programs. The award has an ultimate completion date of January 30, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,335.98 firm-fixed-price delivery order is for the supply of 4,564,536,275 units of Morphine Sulfate Extended-Release 30 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...